GB201610176D0 - Imaging agents and methods of use - Google Patents
Imaging agents and methods of useInfo
- Publication number
- GB201610176D0 GB201610176D0 GBGB1610176.8A GB201610176A GB201610176D0 GB 201610176 D0 GB201610176 D0 GB 201610176D0 GB 201610176 A GB201610176 A GB 201610176A GB 201610176 D0 GB201610176 D0 GB 201610176D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- methods
- imaging agents
- imaging
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000012216 imaging agent Substances 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
- C09B23/0016—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain the substituent being a halogen atom
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
- C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
- C09B23/083—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines five >CH- groups
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/12—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being branched "branched" means that the substituent on the polymethine chain forms a new conjugated system, e.g. most trinuclear cyanine dyes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1610176.8A GB201610176D0 (en) | 2016-06-10 | 2016-06-10 | Imaging agents and methods of use |
PCT/GB2017/051701 WO2017212298A1 (en) | 2016-06-10 | 2017-06-09 | Imaging agents and methods of use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1610176.8A GB201610176D0 (en) | 2016-06-10 | 2016-06-10 | Imaging agents and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201610176D0 true GB201610176D0 (en) | 2016-07-27 |
Family
ID=56894918
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1610176.8A Ceased GB201610176D0 (en) | 2016-06-10 | 2016-06-10 | Imaging agents and methods of use |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201610176D0 (en) |
WO (1) | WO2017212298A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113229213B (en) * | 2021-05-14 | 2022-06-14 | 福州大学 | Method for realizing pulmonary embolism modeling and noninvasive quantitative detection by marking thrombus with near-infrared fluorescent probe |
CN116726206A (en) * | 2022-03-04 | 2023-09-12 | 浙江省肿瘤医院 | Antibody coupling near infrared II region fluorescent probe, construction method and application |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9910468A (en) * | 1998-05-15 | 2001-01-09 | Nycomed Amersham Plc | Compound, radiometallic complex, preparation for human administration, kit, uses of a compound and a radiometallic complex of the compound, and, fragment of peptide |
US6984373B2 (en) * | 2000-12-23 | 2006-01-10 | Dyax Corp. | Fibrin binding moieties useful as imaging agents |
GB0224799D0 (en) * | 2002-10-25 | 2002-12-04 | Amersham Plc | Improved complex compositions |
-
2016
- 2016-06-10 GB GBGB1610176.8A patent/GB201610176D0/en not_active Ceased
-
2017
- 2017-06-09 WO PCT/GB2017/051701 patent/WO2017212298A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2017212298A1 (en) | 2017-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL304117A (en) | Anti-pvrig antibodies and methods of use | |
IL286316A (en) | Novel micro-dystrophins and related methods of use | |
IL265800A (en) | Anti-lag-3 antibodies and methods of use thereof | |
HK1258058A1 (en) | Anti-tigit antibodies and methods of use | |
IL271025A (en) | Multibiotic agents and methods of using the same | |
HK1252858A1 (en) | Anti-cll-1 antibodies and methods of use | |
SG10201912879YA (en) | Anti-sirp-alpha antibodies and methods of use thereof | |
PT3548033T (en) | Compounds and their methods of use | |
SG10201912563XA (en) | Anti-tim-3 antibodies and methods of use thereof | |
EP3878348C0 (en) | Medical devices and methods of use | |
ZA201905677B (en) | Glycan-interacting compounds and methods of use | |
HK1253049A1 (en) | Glycan-interacting compounds and methods of use | |
IL265957A (en) | Anti-c1s antibodies and methods of use thereof | |
IL267671A (en) | Pyrazolopyrimidine compounds and methods of use thereof | |
GB201707342D0 (en) | Imaging agents and methods | |
IL265955A (en) | Therapeutic compounds and methods of use thereof | |
IL285928A (en) | Fulvestrant formulations and methods of their use | |
GB201609786D0 (en) | Compounds and method of use | |
IL262647A (en) | Methods and devices for preparation of ultrasound contrast agents | |
GB201814832D0 (en) | Shoulder braces and methods of use | |
HK1258850A1 (en) | Anti-tpbg antibodies and methods of use | |
EP3548021A4 (en) | Imaging agents and methods of use | |
GB201610176D0 (en) | Imaging agents and methods of use | |
GB201608788D0 (en) | Imaging agents and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |